Concourse Financial Group Securities’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Concourse Financial Group Securities’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,576	Closed	-$68.1K	–	2381
2023 Q1	$67.2K	Buy	2,576 +46	+2%	+$1.23K	0.01%	985
2022 Q4	$69.4K	Sell	2,530 -923	-27%	-$24.6K	0.01%	950
2022 Q3	$83K	Buy	3,453 +626	+22%	+$16.2K	0.01%	787
2022 Q2	$75K	Buy	+2,827	New	+$74.7K	0.01%	922

Other funds holding FTXH

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

WFA

WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return

KNW

Kesler Norman & Wride Ogden, Utah $631M AUM 27.63% 1-Year Est. Return

PPWM

Paragon Private Wealth Management Lexington, Kentucky $383M AUM 36.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Concourse Financial Group Securities's FTXH Position: Q2 2023 in Review

Concourse Financial Group Securities sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2023, closing a stake of 2,576 shares — an estimated $68.1K sold.

Concourse Financial Group Securities first reported a position in FTXH in Q2 2022 and held it in 4 quarters. The position peaked at $83K in Q3 2022. 25 funds tracked by Wall St. Rank hold FTXH as of Q2 2023.

Concourse Financial Group Securities reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q2 2023 after selling out during the quarter.
Concourse Financial Group Securities sold 2,576 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2023, an estimated $68.1K.
Concourse Financial Group Securities first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2022 and held it in 4 quarters.
Concourse Financial Group Securities's First Trust Nasdaq Pharmaceuticals ETF position peaked at $83K in Q3 2022.
25 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2023.

Based on Concourse Financial Group Securities's 13F filing for Q2 2023, filed 10 Aug 2023.